7-(4-Chlorophenyl)-2-(3-hydroxypropyl)-5-methyl-N-(pyridin-3-yl)-1,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide

Catalog No. :
ACYZUL862
CAS No. :
539810-41-8
Molecular Formula :
C21H21ClN6O2
Molecular Weight :
424.89

IUPAC Name:7-(4-chlorophenyl)-2-(3-hydroxypropyl)-5-methyl-N-(pyridin-3-yl)-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide

7-(4-Chlorophenyl)-2-(3-hydroxypropyl)-5-methyl-N-(pyridin-3-yl)-1,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(4-Chlorophenyl)-2-(3-hydroxypropyl)-5-methyl-N-(pyridin-3-yl)-1,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide
IUPAC Name7-(4-chlorophenyl)-2-(3-hydroxypropyl)-5-methyl-N-(pyridin-3-yl)-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide
Molecular FormulaC21H21ClN6O2
Molecular Weight424.89
SMILESO=C(C1=C(C)N=C2N(NC(CCCO)=N2)C1C3=CC=C(Cl)C=C3)NC4=CC=CN=C4
InChI KeyPXJLLAIYUIDQFE-UHFFFAOYSA-N
Synonym7-(4-chlorophenyl)-2-(3-hydroxypropyl)-5-methyl-N-pyridin-3-yl-1,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide;[1,2,4]Triazolo[1,5-a]pyrimidine-6-carboxamide, 7-(4-chlorophenyl)-1,7-dihydro-2-(3-hydroxypropyl)-5-methyl-N-3-pyridinyl-
CAS No.539810-41-8

Synthetic Route by SureRoute

1. ACYZUL862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYZUL862 route product structure diagram
    ACYZUL862539810-41-8
Inquiry

2. ACYZUL862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYZUL862 route product structure diagram
    ACYZUL862539810-41-8
Inquiry

Comments (0)